Clinical Advances in Radiation Therapy for Cancers

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nuclear Medicine & Radiology".

Deadline for manuscript submissions: 25 December 2025 | Viewed by 95

Special Issue Editors


E-Mail Website
Guest Editor
Department of Oncology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 37 Dionisie Lupu Str, 030167 Bucharest, Romania
Interests: radiation oncology; radiotherapy; cancer radiotherapy; cancer radiation therapy; radiation oncology; radiobiology; immunotherapy; targeted therapy; multimodal therapy; clinical trials; hadrontherapy
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Laboratory of Molecular Nanotechnologies, National Institute for Research and Development in Microtechnologies IMT-Bucharest, 126A Erou Iancu Nicolae Str., 077190 Voluntari, Romania
2. Department of Oncology, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 37 Dionisie Lupu Str, 030167 Bucharest, Romania
Interests: radiation oncology; radiotherapy; cancer radiotherapy; cancer radiation therapy; radiation oncology; radiobiology; predictive and prognostic biomarkers; cancer treatment; heavy ions radiation oncology; protontherapy; cancer biolology

E-Mail Website
Guest Editor
Department of Oncology, Faculty of Medicine and Pharmacy, Dunarea de Jos University of Galati, 35 Alexandru Ioan Cuza Str, 800216 Galati, Romania
Interests: radiation oncology; cancer radiation therapy; radiation oncology; immunotherapy; targeted therapy; clinical trials; biological oncology

Special Issue Information

Dear Colleagues,

Radiation therapy remains a cornerstone in cancer treatment, continuously evolving through technological advancements and innovative therapeutic strategies. This Special Issue in explores the latest progress in radiation oncology, addressing key developments in radiotherapy techniques, radiobiology, and multimodal cancer treatment.

Recent innovations in proton therapy and heavy ion radiation oncology have improved treatment precision, reducing toxicity and enhancing patient outcomes. The integration of predictive and prognostic biomarkers enables personalized radiotherapy, optimizing efficacy and minimizing adverse effects. Advances in radiobiology contribute to a better understanding of tumor response and resistance mechanisms, guiding novel therapeutic strategies. Within multimodal therapeutic strategies, radiotherapy is combined with immunotherapy, targeted therapy, and chemotherapy to enhance anti-tumor efficacy.

In this Special Issue we welcome original research papers and reviews on emerging radiation therapy techniques, biomarker-driven radiation strategies, clinical applications of particle therapy, and novel combination therapies. We welcome papers reporting clinical trials of various dimensions; validating new radiation approaches and exploring their synergy with systemic treatments is also highlighted. Translational research papers on radiobiology and biomarker-based radiation or multimodal therapy indications are also welcome. 

Prof. Dr. Rodica Maricela Anghel
Dr. Liviu Bîlteanu
Dr. Laura Florentina Rebegea
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • radiation oncology
  • radiotherapy
  • cancer radiotherapy
  • cancer radiation therapy
  • radiobiology
  • predictive and prognostic biomarkers
  • cancer treatment
  • heavy ions radiation oncology
  • protontherapy
  • cancer biolology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop